ArgenTAG

ArgenTag is a private, pre-revenue life science tools company pioneering single-cell long-read sequencing. Founded in 2016 and based in San Diego, the company has developed a proprietary library preparation kit that is compatible with PacBio and Oxford Nanopore sequencers, enabling researchers to move beyond short-read sequencing fragments to capture complete transcriptomes from individual cells. The company has secured strategic funding from notable venture capital firms and is currently running an Early Access program for its flagship product. With a seasoned leadership team and high-profile scientific advisors like George Church, ArgenTag is positioned to capitalize on the growing demand for more detailed single-cell genomic insights.

Proprietary Single-Cell RNA Library Kit designed natively for long-read sequencing (PacBio and Oxford Nanopore) to enable full-length transcript isoform analysis at single-cell resolution.

ArgenTag's direct competitors are few, as it pioneers a specific tool category. However, it competes indirectly with all providers of short-read single-cell solutions (e.g., 10x Genomics, Parse Biosciences) and companies developing alternative long-read compatible methods. Competition may also emerge from the sequencing platform companies themselves developing integrated single-cell long-read solutions. ArgenTag's differentiation is its focused, platform-agnostic kit designed specifically for this technical challenge.